COHANCE LIFESCIENCES LTD
NSE: COHANCE · Healthcare
₹445.40
-3.35 (-0.75%)
Last close · 30 Aug 2026, 2:50 am IST
- Open
- ₹449.75
- Day high
- ₹450.00
- Day low
- ₹441.00
- Volume
- 6.35 L
- Prev close
- ₹448.75
HealthcareDrug Manufacturers - Specialty & GenericPart of:All NSE StocksNifty 500Nifty MidSmallcap 400Nifty Smallcap 250
Price chart
Range
EMA
Also show
Fundamentals
Drug Manufacturers - Specialty & Generic
Valuation
- Market Cap
- 15,958 Cr
- Price
- 417.10
- P/E (TTM)
- 89.31
- P/E (Fwd)
- 40.83
- P/B
- 4.09
- EV/EBITDA
- 37.91
- EV/Revenue
- 7.14
- PEG
- —
- Div Yield
- —
- 52W High
- 1,038.90
- 52W Low
- 266.70
- Beta
- 0.56
Profitability & income
- Revenue (TTM)
- 2,269 Cr
- Net Income (TTM)
- 179 Cr
- EBITDA
- 427 Cr
- Gross Margin
- 70.79%
- Op. Margin
- 7.66%
- Net Margin
- 7.90%
- ROE
- 3.84%
- ROA
- 2.67%
- EPS (TTM)
- 4.67
- EPS (Fwd)
- 10.22
Financial health
- Total Debt
- 400 Cr
- Total Cash
- 326 Cr
- Debt/Equity
- 9.93
- Current Ratio
- 2.83
- Quick Ratio
- 1.56
- Book Value
- 102.03
- Free Cash Flow
- 49 Cr
- Op. Cash Flow
- 368 Cr
Growth
- Revenue Growth
- -26.30%
- Earnings Growth
- -89.00%
- Earnings QoQ
- -83.80%
Quarterly results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 619 Cr | 20 Cr | 80 Cr | 47 Cr | 405 Cr | — | 400 Cr | 3,911 Cr |
| 2025-12-31 | 545 Cr | 37 Cr | 97 Cr | 48 Cr | 386 Cr | — | — | — |
| 2025-09-30 | 556 Cr | 74 Cr | 137 Cr | 77 Cr | 414 Cr | — | 451 Cr | 3,788 Cr |
| 2025-06-30 | 549 Cr | 49 Cr | 118 Cr | 67 Cr | 401 Cr | — | — | — |
| 2025-03-31 | 840 Cr | 120 Cr | 225 Cr | 175 Cr | 540 Cr | — | 279 Cr | 1,697 Cr |
| 2024-12-31 | — | — | — | — | — | — | — | — |
Annual results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 2,269 Cr | 179 Cr | 432 Cr | 240 Cr | 1,606 Cr | 368 Cr | 400 Cr | 3,911 Cr |
| 2025-03-31 | 2,609 Cr | 487 Cr | 850 Cr | 630 Cr | 1,792 Cr | 673 Cr | 279 Cr | 1,697 Cr |
| 2024-03-31 | 1,034 Cr | 300 Cr | 467 Cr | 354 Cr | 716 Cr | 385 Cr | 65 Cr | 2,051 Cr |
| 2023-03-31 | 1,331 Cr | 411 Cr | 621 Cr | 526 Cr | 745 Cr | 457 Cr | 70 Cr | 1,735 Cr |
| 2022-03-31 | — | — | — | — | — | — | — | — |
Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.
Want charts and signals for COHANCE?
Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.
Sign in